Normochromic anemia: Difference between revisions
Jump to navigation
Jump to search
m Robot: Changing Category:Diseases to Category:Disease |
m Robot: Automated text replacement (-{{SIB}} +, -{{EH}} +, -{{EJ}} +, -{{Editor Help}} +, -{{Editor Join}} +) |
||
| Line 2: | Line 2: | ||
{{CMG}} | {{CMG}} | ||
==Overview== | ==Overview== | ||
| Line 17: | Line 17: | ||
{{reflist}} | {{reflist}} | ||
{{Myeloid hematologic disease}} | {{Myeloid hematologic disease}} | ||
{{WH}} | {{WH}} | ||
{{WS}} | {{WS}} | ||
[[Category:Disease]] | [[Category:Disease]] | ||
Revision as of 14:23, 20 August 2012
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Normocytic anemia is a common issue that occurs for men and women typically over 85 years old. Its prevalence increases with age, reaching 44 percent in men older than 85 years.[1] Normocytic anemia is the most frequently encountered type of anemia.[1]
Causes
The issue is thought of as representing any of the following:
- a decreased production of normal-sized red blood cells (e.g., anemia of chronic disease, aplastic anemia);
- an increased destruction or loss of red blood cells (e.g., hemolysis, posthemorrhagic anemia);
- an uncompensated increase in plasma volume (e.g., pregnancy, fluid overload);
- or a mixture of conditions producing microcytic and macrocytic anemia.[1]